Facilitators and Challenges in Oral Health Care for Iranian Patients Undergoing Opioid Maintenance Treatment: A Qualitative Study

Document Type : Original Article

Authors

1 Department of Oral Medicine, Faculty of Dentistry, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

2 Oral and Dental Diseases Research Center, Kerman University of Medical Sciences, Kerman, Iran

3 Social Determinants on Oral Health Research Center, Kerman University of Medical Sciences, Kerman, Iran

4 Department of Oral Medicine, Faculty of Dentistry, Kerman University of Medical Sciences, Kerman, Iran

10.34172/ahj.1662

Abstract

Introduction: This qualitative study aimed to explore the challenges and enablers of oral health care for patients receiving opioid maintenance treatment.
Method: Forty-nine patients under opioid maintenance treatment were included in the study. All interviews were audio recorded and transcribed verbatim. The interview proceeded until data saturation, after which the collected data were analyzed using content analysis methods.
Findings: The most common reasons for problems preventing access to dental services include lack of financial resources, long travel distances (e.g., living in mountainous areas), prioritizing drug seeking, limited availability of dentists, addiction-related indifference, difficulty tolerating waiting times, fear of arrest, lack of time off from work, and prioritizing substance use over dental treatment. Two participants reported that the clinic staff were kind and behaved appropriately. Additionally, seven participants stated that the staff did not discriminate between them and other patients. Regarding dental services, the participants requested that costs be covered, services be insured or free, and that they be informed about suitable service locations.
Conclusion: Patients undergoing maintenance treatment with opioids need more oral and dental health care than the general population. For better access of patients undergoing opioid maintenance treatment to these services, it is better to provide special centers for these people with trained personnel to treat them with insurance coverage.

Highlights

Maryam Alsadat Hashemipour(Google Scholar)(PubMed)

Keywords

References

  1. Banazadeh Mahani N, Kheradmand A, Abedi H. Experiences of opium dependents from performance of methadone centers of kerman, iran. Addict Health 2009;1(2):74–9.
  2. Iranians-die-daily-from-drug-use.2021. Available from https:// www.asriran.com/fa/news/786 838/
  3. Moradi G, Farnia M, Shokoohi M, Shahbazi M, Moazen B, Rahmani K. Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran. Int J Health Policy Manag 2015;4(9):583–9. doi:10.15171/ijhpm.2015.60
  4. Banazadeh M, Khanjari S, Behmaneshpour F, Oskouie F. Parental factors affecting their participation in decision-making for neonates with life-threatening conditions: A qualitative study Parents’ participation in decision-making. J Educ Health Promot 2024;13:316. doi:10.4103/jehp.jehp_991_23
  5. Chen G, Chen Z, Xiao H, Zheng J, Yang S, Wu H. Perceived risk of death among patients with advanced cancer: a qualitative directed content analysis. BMC Palliat Care 2024;23(1):252. doi:10.1186/s12904-024-01584-3
  6. Lindgren BM, Lundman B, Graneheim UH. Abstraction and interpretation during the qualitative content analysis process. Int J Nurs Stud 2020;108:103632. doi:10.1016/j. ijnurstu.2020.103632
  1. Aas CF, Vold JH, Skurtveit S, Odsbu I, Chalabianloo F, Lim AG, et al. Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017. Subst Abuse Treat Prev Policy 2020;15(1):44. doi:10.1186/s13011-020-00286-2
  2. Jörgensen J, Dahlman D, Alanko Blomé M, Janson H, Riesbeck K, Nilsson AC. Staphylococcus aureus carriage and prevalence of skin and soft tissue infections among people who inject drugs: a longitudinal study. Sci Rep 2024;14(1):12919. doi:10.1038/s41598-024-63574-y
  3. Kolla BP, Oesterle T, Gold M, Southwick F, Rummans T. Infectious diseases occurring in the context of substance use disorders: A concise review. J Neurol Sci 2020;411:116719. doi:10.1016/j.jns.2020.116719
  4. Aas CF, Vold JH, Skurtveit S, Lim AG, Ruths S, Islam K, et al. Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway. Subst Abuse Treat Prev Policy 2020;15(1):68. doi:10.1186/s13011-020-00309-y
  5. Kiburi SK, Mwangi J, Maina G. Exploring the experiences of clients receiving opioid use disorder treatment at a methadone clinic in Kenya: a qualitative study. Addict Sci Clin Pract 2022;17(1):71. doi:10.1186/s13722-022-00352-z
  6. Pedrelli P, Iovieno N, Vitali M, Tedeschini E, Bentley KH, Papakostas GI. Treatment of major depressive disorder and dysthymic disorder with antidepressants in patients with comorbid opiate use disorders enrolled in methadone maintenance therapy: a meta-analysis. J Clin Psychopharmacol 2011;31(5):582–6. doi:10.1097/JCP.0b013e31822c0adf
  7. Zhang X, Xu H, Gu J, Lau JT, Hao C, Zhao Y, et al. Depression, suicidal ideation, and related factors of methadone maintenance treatment users in Guangzhou, China. AIDS Care 2016;28(7):851–6. doi:10.1080/09540121.2015.11249 81
  8. Baghaie H, Kisely S, Forbes M, Sawyer E, Siskind DJ. A systematic review and meta-analysis of the association between poor oral health and substance abuse. Addiction 2017;112(5):765–79. doi:10.1111/add.13754
  9. Yazdanian M, Armoon B, Noroozi A, Mohammadi R, Bayat AH, Ahounbar E, et al. Dental caries and periodontal disease among people who use drugs: a systematic review and meta-analysis. BMC Oral Health 2020;20(1):44. doi:10.1186/ s12903-020-1010-3
  10. Kantola KG, Wynn R, Johnsen JK, Hadler-Olsen E. The association between caries experience and demographic, socioeconomic, and psychometric factors among persons with severe psychiatric and/or substance use disorders: a cross-sectional study. Acta Odontol Scand 2025;84:660–72. doi:10.2340/aos.v84.45205
  11. Feng N, Lin C, Hsieh J, Rou K, Li L. Family Related Factors and Concurrent Heroin Use in Methadone Maintenance Treatment in China. Subst Use Misuse 2018;53(10):1674–80. doi:10.1080/10826084.2018.1424913
  12. Davis JP, Eddie D, Prindle J, Dworkin ER, Christie NC, Saba S, et al. Sex differences in factors predicting post-treatment opioid use. Addiction 2021;116(8):2116–26. doi:10.1111/ add.15396
  13. Shamsalina A, Norouzi K, Fallahi Khoshknab M, Farhoudiyan A. Recovery based on spirituality in substance abusers in Iran. Glob J Health Sci 2014;6(6):154–62. doi:10.5539/gjhs. v6n6p154
  14. Magnotti S, Beatty A, Bickford E, Channell I, Weyandt L. Prescription Stimulant Misuse Among Nursing Students: A Systematic Review. J Addict Nurs 2023;34(3):216–23. doi:10.1097/jan.0000000000000539
  15. Zhou Q, Tang R, Yang Y, Ye R, Gao J, Li L, et al. An analysis of factors influencing dropout in methadone maintenance treatment program in Dehong Prefecture of China based on Cox regression and decision tree modelling. BMC Health Serv Res 2025;25(1):439. doi:10.1186/s12913-025-12538-7
  16. Mudiope P, Mutamba BB, Komuhangi L, Nangendo J, Alamo S, Mathers B, et al. Retention of people who inject drugs enrolled in a ‘medications for opioid use disorder’ (MOUD) programme in Uganda. Addict Sci Clin Pract 2024;19(1):39. doi:10.1186/s13722-024-00468-4
  17. Beigi A, Farahani MT, Mohammad-Khani S, Mohammadi- Far MA. The discriminative role of quality of life and hope in narcotic anonymous and methadone maintenance groups. J Clin Psychol 2011; 3:75-84. doi: 10.22075/JCP.2017.2064
  18. Oluwoye O, Kriegel L, Alcover KC, McPherson S, McDonell MG, Roll JM. The dissemination and implementation of contingency management for substance use disorders: A systematic review. Psychol Addict Behav 2020;34(1):99–110. doi:10.1037/adb0000487
  19. Tormohlen KN, Tobin KE, Latkin C. Sources of Stress among Adults with Co-occurring Drug Use and Depressive Symptoms. J Urban Health 2019;96(3):379–89. doi:10.1007/ s11524-018-0304-0
  20. Naseri-Salahshour V, Sajadi M. From Suffering to Indifference: Reaction of Novice Nurses to Ethical Challenges in First Year of Clinical Practice. Iran J Nurs Midwifery Res 2019;24(4):251– 5. doi:10.4103/ijnmr.IJNMR_145_18
  21. Poudel P, Kong A, Hocking S, Whitton G, Srinivas R, Borgnakke WS, et al. Oral health-care needs among clients receiving alcohol and other drugs treatment-A scoping review. Drug Alcohol Rev 2023;42(2):346–66. doi:10.1111/ dar.13583
  22. Hawkins EJ, Lott AMK, Malte CA, Frank AN, Hamilton B, Sayre GG, et al. Patients’ perspectives on care management services for complex substance use disorders. J Addict Dis 2017;36(3):193–206. doi:10.1080/10550887.2017.1326654
  23. Polenick CA, Kaba D, Zhou AN, Han BH, Cotton BP. Dyadic associations between relationship quality and risk of opioid use among couples receiving methadone for opioid use disorder. Drug Alcohol Depend 2021;218:108397. doi:10.1016/j. drugalcdep.2020.108397
  24. Ghasemiesfe M, Barrow B, Leonard S, Keyhani S, Korenstein D. Association Between Marijuana Use and Risk of Cancer: A Systematic Review and Meta-analysis. JAMA Netw Open 2019;2(11):e1916318. doi:10.1001/ jamanetworkopen.2019.16318
  25. Bowes C, Page G, Wassall R, Lloyd C. The need for further oral health research surrounding the provision of dental treatment for people with drug dependency. Br Dent J 2019;227(1):58– 60. doi:10.1038/s41415-019-0469-2
  26. Fan J, Hser YI, Herbeck D. Tooth retention, tooth loss and use of dental care among long-term narcotics abusers. Subst Abus 2006;27(1-2):25–32. doi:10.1300/J465v27n01_04
  27. Bickel WK, Johnson MW, Koffarnus MN, MacKillop J, Murphy JG. The behavioral economics of substance use disorders: reinforcement pathologies and their repair. Annu Rev Clin Psychol 2014;10:641–77. doi:10.1146/annurev-clinpsy-032813-153724
  28. Cossa F, Piastra A, Sarrion-Pérez MG, Bagán L. Oral manifestations in drug users: A review. J Clin Exp Dent 2020;12(2):e193–e200. doi:10.4317/jced.55928
  29. Åstrøm AN, Virtanen J, Özkaya F, Fadnes LT. Oral health related quality of life and reasons for non-dental attendance among patients with substance use disorders in withdrawal rehabilitation. Clin Exp Dent Res 2022;8(1):68–75. doi:10.1002/cre2.476
  30. Smith CS. Applying a systems oriented ethical decision making framework to mitigating social and structural determinants of health. Front Oral Health 2023;4:1031574. doi:10.3389/ froh.2023.1031574
  31. Carlsen SL, Isaksen K, Åstrøm AN, Fadnes LT. Facilitators for use of oral healthcare services among people with substance use disorders: a qualitative study in Norway. Acta Odontol Scand 2022;80(7):513–21. doi:10.1080/00016357.2022.204 1719
  32. Åstrøm AN, Özkaya F, Virtanen J, Fadnes LT. Dental health care workers’ attitude towards patients with substance use disorders in medically assisted rehabilitation (MAR). Acta Odontol Scand 2021;79(1):31–6. doi:10.1080/00016357.20 20.1769856
  33. Steiro A, Hestevik CH, Muller AE. Patient’s and healthcare provider’s experiences with Opioid Maintenance Treatment (OMT): a qualitative evidence synthesis. BMC Health Serv Res 2024;24(1):333. doi:10.1186/s12913-024-10778-7
  34. Shekarchizadeh H, Khami MR, Mohebbi SZ, Ekhtiari H, Virtanen JI. Oral Health of Drug Abusers: A Review of Health Effects and Care. Iran J Public Health 2013;42(9):929–40.
  35. Sengupta A, Fatema K, Patterson-Norrie T, Kezhekkekara S, Poudel P, Whitton G, et al. Perceptions of clinicians on promoting oral health care in an alcohol and other drug use health care service: A qualitative study. Drug Alcohol Rev 2025;44(3):742–53. doi:10.1111/dar.14016
  36. Zhang J, Liu W, Shi L, Liu X, Wang M, Li W, et al. The Effects of Drug Addiction and Detoxification on the Human Oral Microbiota. Microbiol Spectr 2023;11(2):e0396122. doi:10.1128/spectrum.03961-22
  37. Carlsen SL, Isaksen K, Fadnes LT, Lygren OJS, Åstrøm AN. Non-financial barriers in oral health care: a qualitative study of patients receiving opioid maintenance treatment and professionals’ experiences. Subst Abuse Treat Prev Policy 2021;16(1):44. doi:10.1186/s13011-021-00379-6
  38. Marques TC, Sarracini KL, Cortellazzi KL, Mialhe FL, de Castro Meneghim M, Pereira AC, et al. The impact of oral health conditions, socioeconomic status and use of specific substances on quality of life of addicted persons. BMC Oral Health 2015;15:38. doi:10.1186/s12903-015-0016-8
  39. Ehsani H, Dindarloo MM, Lotfizadeh A, Alizadeh F, Alipour A, Alaedini K, et al. Oral Health-Related Quality of Life and Oral Health Indices in Patients With Opioid Use Disorder Undergoing Methadone Maintenance Treatment. Int J Dent 2025;2025:5339532. doi:10.1155/ijod/5339532
  40. Hovden ES, Ansteinsson VE, Klepaker IV, Widström E, Skudutyte-Rysstad R. Dental care for drug users in Norway: dental professionals’ attitudes to treatment and experiences with interprofessional collaboration. BMC Oral Health 2020;20(1):299. doi:10.1186/s12903-020-01240-1
  41. Brondani MA, Alan R, Donnelly L. Stigma of addiction and mental illness in healthcare: The case of patients’ experiences in dental settings. PLoS One 2017;12(5):e0177388. doi:10.1371/journal.pone.0177388
  42. Cheah AL, Pandey R, Daglish M, Ford PJ, Patterson S. A qualitative study of patients’ knowledge and views of about oral health and acceptability of related intervention in an Australian inpatient alcohol and drug treatment facility. Health Soc Care Community 2017;25(3):1209–17. doi:10.1111/ hsc.12423
  43. Rossow I. Illicit drug use and oral health. Addiction 2021;116(11):3235–42. doi:10.1111/add.15360
  44. Watanabe Y, Okada K, Kondo M, Matsushita T, Nakazawa S, Yamazaki Y. Oral health for achieving longevity. Geriatr Gerontol Int 2020;20(6):526–38. doi:10.1111/ggi.13921
  45. Ramey T, Regier PS. Cognitive impairment in substance use disorders. CNS Spectr 2019;24(1):102–13. doi:10.1017/ s1092852918001426
Addiction & Health
Volume 18
Pages 1-10

Files

Share

How to cite

Statistics